β¨ Health Notices
NEW ZEALAND GAZETTE, No. 75 β 25 AUGUST 2016
lead clinician for Taranaki District Health Board Alcohol and Drug Service;
b. authorise in writing service/clinic medical practitioners as specified under subsection (2)(b) to:
i. prescribe, administer or supply controlled drugs for the treatment of dependence;
ii. authorise in writing general practitioners receiving clients from Taranaki District Health Board Alcohol and Drug Service as specified under subsection (2)(d); and
c. authorise in writing general practitioners receiving clients from Taranaki District Health Board Alcohol and Drug Service as specified under subsection (2)(d).
Conditions
-
Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Taranaki District Health Board Alcohol and Drug Service.
-
This approval expires on 31 December 2017.
Dated at Wellington this 18th day of August 2016.
DR JOHN CRAWSHAW, Director of Mental Health.
2016-go4805
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Glycopyrronium Bromide 0.5mg/mL and Neostigmine Metilsulfate 2.5mg/mL Injection
Active Ingredients: Glycopyrronium bromide 0.5mg/mL
Neostigmine metilsulfate 2.5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Max Health Limited
Manufacturer: Martindale Pharmaceuticals, Essex, United Kingdom
Product: Oxycodone Controlled Release Actavis
Active Ingredient: Oxycodone hydrochloride 5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturers: Actavis ehf, Hafnarfjordur, Iceland
Balkanpharma Dupnitsa AD, Dupnitsa, Bulgaria
Product: Oxycodone Controlled Release Actavis
Active Ingredient: Oxycodone hydrochloride 10mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturers: Actavis ehf, Hafnarfjordur, Iceland
Balkanpharma Dupnitsa AD, Dupnitsa, Bulgaria
Product: Oxycodone Controlled Release Actavis
Active Ingredient: Oxycodone hydrochloride 15mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturers: Actavis ehf, Hafnarfjordur, Iceland
Balkanpharma Dupnitsa AD, Dupnitsa, Bulgaria
Product: Oxycodone Controlled Release Actavis
Active Ingredient: Oxycodone hydrochloride 20mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturers: Actavis ehf, Hafnarfjordur, Iceland
Balkanpharma Dupnitsa AD, Dupnitsa, Bulgaria
57
Next Page →
β¨ LLM interpretation of page content
π₯
Approval of Taranaki District Health Board Alcohol and Drug Service and Clinician to Provide Substitution Treatment Under Section 24 of the Misuse of Drugs Act 1975
(continued from previous page)
π₯ Health & Social Welfare18 August 2016
Approval, Misuse of Drugs Act, Taranaki District Health Board, Alcohol and Drug Service, Substitution Treatment, New Plymouth
- DR JOHN CRAWSHAW, Director of Mental Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Glycopyrronium Bromide, Neostigmine Metilsulfate, Oxycodone
NZ Gazette 2016, No 75